Clinical study of Wenjing decoction combined with dydrogesterone in the treatment of pelvic pain with deep infiltrating endometriosis
- Conditions
- Endometriosis
- Registration Number
- ITMCTR2200005849
- Lead Sponsor
- the Third Affiliated Hospital of Zhejiang Chinese University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- Not specified
a Complaints of pelvic pain, with a VAS score of 4 or above;
b Meet the diagnostic criteria for deep infiltrating endometriosis;
c Comply with the syndrome of cold coagulation and blood stasis;
d Female, between 18-45 years old; menstrual cycle is regular, the menstrual cycle is 21-35 days;
e Those who have not taken hormone drugs in the past 3 months;
f There is no pregnancy plan during the medication period, and contraceptive contraception is used;
g Those who voluntarily participate in this trial and have signed an informed consent form.
a Combined with adenomyosis, pelvic inflammatory mass, and endometriotic cyst diameter = 4cm;
b DIE The lesion penetrates the rectal mucosa and bladder mucosa, and the lesion compresses the ureter to cause transfusion.
Urinary tube dilation, hydronephrosis;
c Patients with malignant tumors of reproductive organs or other malignant tumors;
d People with serious or mental illnesses such as cardiovascular, cerebrovascular, liver, kidney or hematopoietic system;
e Patients with endometriosis who underwent surgical treatment within 3 months before enrollment;
f Patients planning pregnancy, pregnancy or lactation in the past 3 months.
Study & Design
- Study Type
- Observational study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method VAS score;
- Secondary Outcome Measures
Name Time Method esion size;EHP-5;Serum CA125 level;Serum CA125 level;